This paper is in the following e-collection/theme issue:

Prevention and Health Promotion (986) Cost-Effectiveness and Economics (252) New Methods (944) Cross-Sectional Studies in Public Health (278) Innovations and Technology for Physical Activity Education (742)

Published on in Vol 10 (2024)

This is a member publication of National University of Singapore

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46178, first published .
A Nationwide Physical Activity Intervention for 654,500 Adults in Singapore: Cost-Utility Analysis

A Nationwide Physical Activity Intervention for 654,500 Adults in Singapore: Cost-Utility Analysis

A Nationwide Physical Activity Intervention for 654,500 Adults in Singapore: Cost-Utility Analysis

Authors of this article:

Gregory Ang1, 2 Author Orcid Image ;   Chuen Seng Tan2, 3 Author Orcid Image ;   Yot Teerawattananon2, 4 Author Orcid Image ;   Falk Müller-Riemenschneider2, 3, 5 Author Orcid Image ;   Cynthia Chen2, 3, 6, 7 Author Orcid Image
Article Authors Cited by Tweetations Metrics

    1Department of Statistics and Data Science, National University of Singapore, , Singapore, , Singapore

    2Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, , Singapore, , Singapore

    3Yong Loo Lin School of Medicine, National University of Singapore, , Singapore, , Singapore

    4Health Intervention and Technology Assessment Program, Ministry of Public Health, , Nonthaburi, , Thailand

    5Digital Health Center, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, , Berlin, , Germany

    6Schaeffer Center for Health Policy and Economics, University of Southern California, , Los Angeles, CA, , United States

    7Department of Non-Communicable Disease Epidemiology, The London School of Hygiene & Tropical Medicine, , London, , United Kingdom

    Corresponding Author:

    Cynthia Chen, PhD


    Background: Increasing physical inactivity is a primary risk factor for diabetes and hypertension, contributing to rising health care expenditure and productivity losses. As Singapore’s aging population grows, there is an increased disease burden on Singapore’s health systems. Large-scale physical activity interventions could potentially reduce the disease burden but face challenges with the uncertainty of long-term health impact and high implementation costs, hindering their adoption.

    Objective: We examined the cost-effectiveness of the Singapore National Steps Challenge (NSC), an annual nationwide mobile health (mHealth) intervention to increase physical activity, from both the health care provider perspective, which only considers the direct costs, and the societal perspective, which considers both the direct and indirect costs.

    Methods: We used a Markov model to assess the long-term impact of increased physical activity from the NSC on adults aged 17 years and older. A Monte Carlo simulation with 1000 samples was conducted to compare two situations: the NSC conducted yearly for 10 years against a no-intervention situation with no NSC. The model projected inpatient and outpatient costs and mortality arising from diabetes and hypertension, as well as their complications. Health outcomes were expressed in terms of the quality-adjusted life-years (QALYs) gained. All future costs and QALYs were discounted at 3% per annum. Sensitivity analyses were done to test the robustness of our model results.

    Results: We estimated that conducting the NSC yearly for 10 years with a mean cohort size of 654,500 participants was projected to prevent 6200 diabetes cases (95% credible interval 3700 to 9100), 10,500 hypertension cases (95% credible interval 6550 to 15,200), and 4930 deaths (95% credible interval 3260 to 6930). This led to a reduction in health care costs of SGD (Singapore dollar) 448 million (95% credible interval SGD 132 million to SGD 1.09 billion; SGD 1=US $0.73 for the year 2019). There would be 78,800 (95% credible interval 55,700 to 102,000) QALYs gained. Using a willingness-to-pay threshold of SGD 10,000 per QALY gained, the NSC would be cost-saving. When indirect costs were included, the NSC was estimated to reduce societal costs by SGD 1.41 billion (95% credible interval SGD 353 million to SGD 3.80 billion). The model was most sensitive to changes in the inpatient cost of treatment for diabetes complications, time horizon, and program compliance.

    Conclusions: In this modeling study, increasing physical activity by conducting a yearly nationwide physical activity intervention was cost-saving, preventing diabetes and hypertension and reducing mortality from these diseases. Our results provide important information for decision-making in countries that may consider introducing similar large-scale physical activity programs.

    JMIR Public Health Surveill 2024;10:e46178

    doi:10.2196/46178

    Keywords

    physical activity; mHealth; mobile health; nationwide program; Markov model; diabetes; hypertension; prevention; modeling study; productivity; cost; mortality; cost-effectiveness 


    Physical inactivity is a primary risk factor for diabetes and hypertension [1]. Worldwide, hypertension is a major cause of premature mortality [2], while diabetes is expected to have caused 1.5 million deaths in 2019 [3]. Regular physical activity can potentially reduce the burden of these diseases, decreasing health care expenditure and productivity losses. Globally, physical inactivity is estimated to cost health care systems an equivalent to the purchasing power of US $53.8 billion annually, while in Singapore, the economic cost of physical inactivity is estimated to be equivalent to the purchasing power of US $201 million [4]. Yet, more than 20% of Singaporeans are physically inactive [5].

    Increased physical activity is associated with lower incidence and mortality of certain diseases, such as diabetes and hypertension [6-9]. However, evidence from published physical activity randomized controlled trials (RCTs) is not enough to make informed decisions on the cost-effectiveness of physical activity interventions [10]. RCTs are often conducted on small, targeted samples (eg, high-risk groups) and in controlled settings, which do not mimic real-life circumstances [11]. Systematic reviews of mobile health (mHealth) RCTs also highlight the need for longer follow-ups to evaluate their interventions’ effectiveness [12,13].

    The emergence of mHealth devices such as wearables has facilitated the collection of health-related data [14]. This has enabled more large-scale interventions on individuals’ physical activity behavior [15,16]. Furthermore, wearables, more specifically activity trackers, could increase individuals’ physical activity levels [17]. However, despite the many benefits of increased physical activity, conducting these large-scale interventions still poses significant challenges, including a sizable investment. As such, it would be justifiable to apply model-based evaluation to project the longer-term impact of a large-scale intervention using real-world evidence.

    Cost-effectiveness studies enable policy makers to make informed choices by comparing the costs and benefits of public health interventions, prioritizing the allocation of health funds given resource constraints [18]. Although mHealth is often reputed to be cost-effective, there is limited evidence to back this claim [19]. Furthermore, only a few studies analyze the cost-effectiveness of scaled-up physical activity interventions using an app [15]. According to Rondina et al [15], the first cost-effectiveness study of a commercial physical activity app was only published in 2021. Given the limited evidence, more cost-effectiveness studies of these commercial physical activity apps, which have a longer follow-up period, are warranted.

    The National Steps Challenge (NSC) was first introduced in 2015 by the Health Promotion Board to improve physical activity in Singapore. During each season, which is around 5 months long, participants earned HealthPoints according to their steps accumulated each day. The steps accumulated were objectively measured either using their own tracker or a free NSC tracker. These HealthPoints could then be exchanged for cash vouchers.

    To date, six seasons of the NSC have taken place. Previous articles have provided detailed information on the NSC and evaluated the impact of the program on increasing engagement and physical activity but have not studied its impact on health outcomes [20-23]. This is the first study that evaluates the long-term cost-effectiveness of the NSC and its impact on health. In this study, we adopt a model-based cost-effectiveness analysis for the NSC. We developed the NSC Markov model, a computer simulation of diabetes, hypertension, and their complications in Singaporean adults aged 17 years and older. The model compared two situations: the NSC conducted yearly for 10 years against no NSC. Health outcomes were expressed in terms of the quality-adjusted life-years (QALYs) gained.


    Markov Model

    The NSC Markov model was constructed to estimate the costs and QALYs associated with diabetes, hypertension, and their complications in adults (Figure 1). We chose two diseases—diabetes and hypertension. The literature has shown physical activity has an impact in reducing the incidence and keeping these two diseases under control (see section 2 in Multimedia Appendix 1) [8]. The model first simulates a representative individual from the Singapore population. It then follows this individual, projecting the incidence of morbidity, death, and associated costs and health outcomes over 10 years. The model ran for 10 years, as this time horizon reflected a time period that decision-makers would find useful, given that the NSC has already been conducted for 6 years. The transition probabilities were specified using risk equations. There were three possible physical activity levels for each of the health states (healthy, diabetes and hypertension): inactive physical activity, low physical activity, and moderate to high physical activity. We modeled cardiovascular disease (CVD) as the main complication for diabetes and stroke as the main complication for hypertension. We took a conservative approach in estimating the benefits of the intervention by excluding comorbidity of diabetes and hypertension as well as other complications. Increased physical activity was assumed to decrease the risk of morbidities and the risk of mortality. The relative risks of diabetes, hypertension, and death for low and moderate to high physical activity compared to inactive physical activity were obtained from published literature [6-9].

    ‎
    Figure 1. Structure of the National Steps Challenge (NSC) Markov model. Shown is the Markov model used to project costs, diabetes, hypertension, and quality-adjusted life-years of eligible adults for the NSC. The solid ovals denote the different states; the arrows denote possible transitions between states. Mod-to-High: moderate to high; PA: physical activity.

    The model compared two situations: the intervention situation had the NSC conducted yearly for 10 years against a no-intervention situation with no NSC. The cycle length was one year, with half-cycle corrections on costs and QALYs. We accounted for the health gained due to the increased physical activity from the NSC and for the payer’s direct costs of treatment for diabetes and hypertension by adopting the health system perspective. Societal costs were also estimated by adopting the societal perspective (Table S1 in Multimedia Appendix 1) [24,25]. All future costs and QALYs were discounted at 3% per annum [26].

    Full details can be found in Multimedia Appendix 1. A presentation summary is also provided in Multimedia Appendix 2.

    Sample

    We used data from the NSC to estimate the increase in physical activity for a closed cohort of Singapore residents aged 17 years and older. The age distribution of residents was obtained from the population census (Table S2 in Multimedia Appendix 1) [27].

    The size of the NSC cohort was estimated to consist of 1.7 million unique participants registered across seasons 1 to 6 [28]. Also, a separate NSC study found that among 690,233 participants who signed up for NSC Season 3, 266,000 (38.5%) participants synced their trackers until the end of the challenge period [22]. Thus, using the same percentage of participants who continued to sync their trackers until the end of the NSC, we projected based on a closed cohort of 654,500 participants out of 1.7 million who had registered.

    Diseases and Mortality

    Diabetes and hypertension prevalence rates (Figure S1 in Multimedia Appendix 1) and physical activity prevalence rates (Table B1 in Multimedia Appendix 1) were obtained from the 2010 National Health Survey [29]. The 2010 National Health Survey was chosen because we wanted the prevalence before NSC implementation in 2015. Diabetes and hypertension incidence rates, as well as their complications, were obtained from the Multi-Ethnic Cohort, a comprehensive study of 14,465 adults in Singapore (Figure S2, Table S1 in Multimedia Appendix 1) [30]. A multivariable probit regression was used to model the disease incidence, controlling for gender, race, educational attainment, age, BMI, marital status, and smoking. The transition probabilities from healthy to the disease for the different physical activity levels were computed using the disease incidence and their respective relative risk ratios (Table S1 in Multimedia Appendix 1) [6-9]. The mortality rates were extracted from the population census (Table S3 in Multimedia Appendix 1) [31]. The relative mortality risk ratios for the different physical activity levels and different diseases were obtained from relevant literature (Table S1 in Multimedia Appendix 1) [8,32,33].

    Costs and Utility Values of Health States

    All costs were expressed in the Singapore dollar (SGD), where SGD 1=US $0.73=€0.66=CAD $0.98 for the year 2019 [34]. The direct costs of the diseases were computed using the inpatient and outpatient costs. The annual inpatient cost associated with treating diseases was obtained from the Ministry of Health using the median unsubsidized costs (Table S1 in Multimedia Appendix 1) [35]. The annual outpatient cost associated with treating diseases was obtained from relevant literature (Table S1 in Multimedia Appendix 1) [36,37]. For the diseases with no complications, the proportion of inpatient cases was also obtained from relevant literature (Table S1 in Multimedia Appendix 1) [36,38]. It was assumed that all diseases with complications were treated as inpatient cases. The total Health Promotion Board program and marketing expenses were SGD 120 million in 2018 [39]. Apart from the NSC, the Health Promotion Board conducts many national public health programs such as smoking cessation (IQuit program), eating healthily (My Healthy Plate), screening (Screen For Life), and vaccination programs for all ages, among others [40]. As the NSC reached out to 1.7 million participants, we applied a conservative approach, assuming that 30% of the Health Promotion Board budget was used for the NSC alone, with an annual cost of SGD 36 million. To incorporate the indirect costs of the diseases, the ratios of direct to indirect costs from a societal perspective were obtained from relevant literature (Table S1 in Multimedia Appendix 1) [24,25]. Health outcomes were evaluated based on utilities obtained for disease states and different physical activity levels (Table S1 in Multimedia Appendix 1) [6,41,42]. Utility values ranged from 0 (dead) to 1 (perfect health).

    Willingness-to-Pay Threshold

    The Ministry of Health Agency for Care Effectiveness in Singapore did not provide a fixed willingness-to-pay threshold but a range of incremental cost-effectiveness ratios (ICERs) for the base case, with the lowest ICER at SGD 15,000 per QALY gained [26]. As the NSC is a physical activity intervention, the willingness-to-pay for preventive interventions might be lower than for medical interventions [43]. Hence, we used a lower willingness-to-pay threshold of SGD 10,000 per QALY gained.

    Estimation of Results

    Overview of Analyses

    In the previous subsections, we have described the parameters used for the base case. Scenario analysis, one-way deterministic sensitivity analysis, deterministic threshold sensitivity analysis, and probabilistic sensitivity analysis were done to assess the robustness of our model results in the base case to changes in key parameters over plausible ranges. All analyses were conducted in R version 4.1.2 (R Foundation for Statistical Computing).

    Scenario Analysis

    We examined the differentiation of cost among different physical activity levels within each health state. The base case assumed equal costs among different physical activity levels within each health state. As previous studies in the United States [44] and European Union [45] have found that higher physical activity levels reduced health care costs, we varied the costs for different physical activity levels within the same disease state, inflating the inactive physical activity states’ costs by 5% and deflating the costs for the moderate to high physical activity states by 5%. We assumed that physical activity helps to manage chronic diseases better, resulting in lower doctor visits and lower doses of medication, thus reducing medical costs by 5%.

    Sensitivity Analyses

    One-way deterministic sensitivity analysis was performed on 33 parameters by varying each parameter over their respective 95% confidence intervals (except inpatient and outpatient costs, program cost, program compliance, and time horizon), interquartile range (inpatient and ourpatient costs), and inflating (or deflating) the parameters by 30% (program cost, program compliance, and time horizon), while keeping the other parameters fixed (Table S1 in Multimedia Appendix 1). Deterministic threshold sensitivity analysis was performed on the three most sensitive parameters from the one-way deterministic sensitivity analysis.

    Probabilistic sensitivity analysis was implemented by varying all 32 parameters (except time horizon) simultaneously using a Monte Carlo simulation with 1000 bootstrap samples, using prespecified distributions (Table S1 in Multimedia Appendix 1). The time horizon of 10 years was not varied, as this can be decided by the policy maker. Point estimates of cases averted, health care costs, QALYs gained, and the ICER (cost per QALY gained) were obtained by the mean of the 1000 bootstrap samples, and 95% credible intervals were obtained using the 2.5 and 97.5 percentiles. Lower willingness-to-pay thresholds of SGD 0 and SGD 5000 per QALY gained were also considered.

    Model Validation

    The NSC Markov model was validated with real-world observations. The NSC Markov model’s projections of the 5-year physical activity prevalence rates were compared with observed physical activity levels from NSC Season 5 (Figure S4, Table B1 in Multimedia Appendix 1) [5]. The NSC Markov model’s projections of the 5-year disease prevalence rates were compared with data from the National Population Health Survey (2022) (Table B2 in Multimedia Appendix 1) [46].

    Ethical Considerations

    Ethical approval for this study was obtained from the Institutional Review Board of the National University of Singapore (NUS-IRB LN-18-061E). Informed consent was obtained from all participants. The NSC data were deidentified. Participants were compensated according to the NSC rewards structure [23].


    Base Case

    Conducting the NSC yearly for 10 years with a mean cohort size of 654,500 participants aged 17 years and older was projected to prevent 6200 diabetes cases (95% credible interval 3700-9100), 10,500 hypertension cases (95% credible interval 6550-15,200), and 4930 death cases (95% credible interval 3260-6930) (Figure 2A), leading to 78,800 (95% credible interval 55,700-102,000) QALYs gained.

    From the health system perspective, assuming no differentiation of cost among different physical activity levels within each health state, the health care cost savings from the averted cases was estimated to be SGD 448 million (95% credible interval SGD 132 million to SGD 1.09 billion), with SGD 298 million (95% credible interval SGD 34.7 million to SGD 925 million) for diabetes and SGD 150 million (95% credible interval SGD 46.5 million to SGD 328 million) for hypertension (Figure 2B). To achieve these savings, an investment of SGD 309 million (95% credible interval SGD 223 million to SGD 398 million) over 10 years for the program cost was required. Using a willingness to pay threshold of SGD 10,000, the NSC was cost-saving. From the societal perspective, the NSC was estimated to reduce societal costs by SGD 1.41 billion (95% credible interval SGD 353 million to SGD 3.80 billion) (Table 1) and was even more cost-saving.

    In the Monte Carlo simulations, all of the bootstrap samples (100%) had positive QALYs (Figure 3A), suggesting that the NSC improves health outcomes. From the health system perspective, there was a 68.0%, 99.9%, and 100% probability that the NSC was cost-effective at a willingness-to-pay of SGD 0, SGD 5000, and SGD 10,000 per QALY gained, respectively (Table 1). The cost-effectiveness of the NSC at increasing thresholds is shown in the cost-effectiveness curves (Figure 3B). This suggests that the NSC would be cost-effective at a willingness-to-pay threshold of SGD 10,000 per QALY gained. From the societal perspective (Table 1), there was a 97.7%, 100%, and 100% probability that the NSC was cost-effective at a willingness-to-pay of SGD 0, SGD 5000, and SGD 10,000 per QALY gained, respectively.

    ‎
    Figure 2. Projections from a health system perspective when the National Steps Challenge is conducted yearly for 10 years in the base case. Panel A shows the reductions in diabetes, hypertension, and deaths. Panel B shows the reduction in health care costs, which are expressed in Singapore dollars (SGD; SGD 1=US $0.73 for the year 2019).
    Table 1. Projected estimates of the cost and effectiveness if the NSCa is conducted yearly for 10 years.b
    PerspectivecAdjustment of costs due to PAd,eReduction in costs, in billions of SGDf,g (95% credible interval)ICERh (costs per QALYi gained), in thousands of SGDjCost-effectiveness (%)k
    SGD 0 per QALY gainedSGD 5000 per QALY gainedSGD 10,000 per QALY gained
    Base case
     Health systemEqual0.448 (0.13-1.09)Cost-savingl68.099.9100
     SocietalEqual1.41 (0.353-3.80)Cost-savingl97.7100100
    Scenario analysis
     Health system5%0.518 (0.182-1.19)Cost-savingl82.0100100
     Societal5%1.62 (0.481-3.99)Cost-savingl99.7100100

    aNSC: National Steps Challenge.

    bWe assumed a 3% discount rate. For all the scenarios, including the base case, the simulated cohort size was 657,000 (469,000-844,000). The total program cost over 10 years was SGD 309 million (SGD 223 million to SGD 398 million). The QALYs gained were 78.8 thousand (55.7 thousand to 102 thousand). The brackets show the 95% credible intervals, which are obtained by the 2.5 and 97.5 percentiles of the 1000 bootstrap samples.

    cHealth system perspective only considers the direct cost of treatment of diseases. Societal perspective considers both the direct and indirect costs of treatment of diseases.

    dFor each disease state, we considered two settings. In the first setting, we assumed equal costs within the different physical activity levels (ie, equal). In the second setting, we used the costs for the low physical activity level as a benchmark and assumed a 5% lower cost for the moderate to high physical activity level and a 5% higher cost for the inactive physical activity level (ie, 5%).

    ePA: physical activity.

    fSGD: Singapore dollar (SGD 1=US $0.73 for the year 2019).

    gThe reduction in health care costs presented in this column does not take into account the total program cost over 10 years of SGD 309 million (95% credible interval SGD 223 million to SGD 398 million).

    hICER: incremental cost-effectiveness ratio.

    iQALY: quality-adjusted life-year.

    jThe ICER (costs per QALY gained) was calculated by subtracting the reduction in health care costs from the total program cost and dividing the result by the QALYs gained.

    kFor each of the 1000 bootstrap samples, the ICER was computed. The probability that the NSC was cost-effective was calculated by computing the proportion of ICERs that were below the willingness-to-pay threshold (SGD 0, SGD 5000, or SGD 10,000 per QALY gained).

    lThe NSC was cost-saving if the QALY gained is positive and the reduction in health care costs exceeds the program cost. Hence, when the NSC is cost-saving, the ICER is negative.

    ‎
    Figure 3. Results of probabilistic and one-way deterministic sensitivity analyses from a health system perspective when the NSC is conducted yearly over 10 years in the base case. Panel A shows the simulated incremental costs (in SGD; SGD 1=US $0.73 for the year 2019) and QALYs gained (green) from the probabilistic sensitivity analysis. The incremental cost is computed by subtracting the reduction in health care costs from the total program cost. The mean of the 1000 bootstrap samples was also plotted (purple). In each bootstrap sample, the NSC was cost-effective if the simulated point (green point) is below the willingness-to-pay threshold (red dotted lines). The percentages next to the willingness to pay are the proportion of bootstrap samples below the threshold, which estimates the probability that the NSC was cost-effective. Panel B shows the cost-effectiveness acceptability curve. With reference to panel A, the points (0, 0.680), (5000, 0.999), and (10,000, 1) lie on the blue curve in panel B. The remaining points on the blue curve in panel B were obtained by varying the willingness-to-pay threshold and computing the proportion of bootstrap samples below that threshold. The red curve is obtained by subtracting the proportion of bootstrap samples below the willingness-to-pay threshold (blue curve) from 1. Panel C shows the results of the one-way sensitivity analyses where model parameters were varied across a range of plausible values to see the impact on the cost per QALY gained. The deterministic ICER is obtained using the model parameters’ mean (or median for skewed parameters; eg, costs). The top 8 parameters (out of 33) to which the model was most sensitive are shown. Plausible ranges were preferentially derived from reported 95% confidence intervals or ranges or from calculated 95% confidence intervals, using standard errors as available, except for the inpatient rates, inpatient and outpatient treatment costs, program cost, program compliance, and time horizon. The interquartile range was used for the inpatient and outpatient treatment costs, and inflating/deflating the means by 30% was used for the inpatient rates, program cost, program compliance, and time horizon. ICER: incremental cost-effectiveness ratio; NSC: National Steps Challenge; QALY: quality-adjusted life-year; WTP (Prob CE): willingness-to-pay (probability that the NSC was cost-effective).

    Scenario Analysis

    From the health system perspective (Table 1), assuming a differential cost of 5% among participants with the same disease but with different physical activity levels, conducting the NSC yearly for 10 years with a mean cohort size of 654,500 participants was estimated to reduce health care costs by SGD 518 million (95% credible interval SGD 182 million to SGD 1.19 billion). After accounting for the program cost, the NSC was cost-saving (ie, improves health outcomes and the reduction of health care costs exceeds the program cost). There was a 82.0%, 100% and 100% probability that the NSC was cost-effective at a willingness-to-pay of SGD 0, SGD 5000, and SGD 10,000 per QALY gained, respectively. From the societal perspective (Table 1), there was a 99.7%, 100%, and 100% probability that the NSC was cost-effective at a willingness-to-pay of SGD 0, SGD 5000, and SGD 10,000 per QALY gained, respectively.

    One-Way Deterministic Sensitivity Analysis

    From the health system perspective, the uncertainty ranges of individual parameters had an effect on the cost-effectiveness of the NSC (ICER range: cost-saving to SGD 1260 per QALY gained) (Figure 3C). The three parameters that the model was most sensitive to were (1) changes in the inpatient cost of treatment for diabetes with complications, (2) time horizon, and (3) program compliance. The model was also sensitive to changes in the disease incidence rate, the program costs, inpatient costs of treatment for hypertension with complications, and the relative risk of disease due to moderate to high physical activity compared to inactive physical activity for diseases with complications (diabetes and hypertension).

    Deterministic Threshold Sensitivity Analysis

    From a health system perspective, the NSC was cost-saving if it is maintained in one of three ways: (1) program compliance was at least 34.7%, (2) the inpatient cost of treatment for diabetes complications was at least SGD 11,100, or (3) the NSC was conducted for at least 10 years.


    Principal Results

    The NSC is an annual nationwide physical activity, having reached 1.7 million participants [28]. Based on a mean cohort size of 654,500 participants, we provide evidence of a cost-effective, scalable intervention with continuous objective activity monitoring of the individual’s physical activity behavior. We project that conducting the NSC yearly for 10 years improves health-related quality of life (as measured by QALYs) and reduces the number of diabetes and hypertension cases. The reduction in cases is estimated to save SGD 448 million in direct health care costs and an additional SGD 965 million when indirect costs such as productivity losses and costs due to early mortality are considered. The QALYs gained and cost savings are realized when the NSC is conducted annually, which delays the onset of diseases due to lower risk from higher physical activity levels.

    An intervention is cost-effective if the cost per QALY gained is less than the willingness-to-pay threshold. Although the Ministry of Health Agency for Care Effectiveness in Singapore’s lowest willingness-to-pay threshold was SGD 15,000 per QALY gained, we chose a willingness-to-pay of SGD 10,000 per QALY gained as the willingness-to-pay threshold for preventive interventions might be lower than for medical interventions [43]. Other willingness-to-pay thresholds can also be considered in evaluating interventions. One common willingness-to-pay threshold is the gross domestic product (GDP) per capita (SGD 82,500 [47]), but this has its limitations [48]. For example, it does not consider if the intervention is affordable or feasible [48]. Another proposed willingness-to-pay threshold is SGD 30,500 per QALY gained, which is Singapore-specific and considers the opportunity costs of health care expenditure [49]. Future research could examine the appropriate willingness-to-pay thresholds for physical activity interventions. Nonetheless, as we set a lower threshold, using any of the aforementioned thresholds does not change our conclusion that the NSC is cost-saving.

    A systematic review of 599 cost-effectiveness studies finds that the distributions of the cost-effectiveness ratios between treatment and preventive measures are similar [50]. While most preventive measures do not save money, they may still represent a reasonable investment and an efficient allocation of resources, as they provide health benefits at a low cost. Our results show that the NSC is a large-scale physical activity program that can deliver cost-effective prevention of noncommunicable diseases such as diabetes and hypertension. Also, with population aging, health care expenditure as a percentage of GDP has been rising, putting pressure on policy makers to keep health care affordable and focus on primary prevention [51]. In addition, the future program cost can be further reduced, as some existing infrastructure can be reused from earlier years, making the NSC more cost-saving. If health care costs rise faster than program costs and general inflation, preventive measures will be more cost-saving.

    Our analysis showed a huge reduction in health care costs when we considered differential costs among participants with the same disease but with different physical activity levels (Table 1). This suggests that minimal change in clinical symptoms and costs for diabetes and hypertension can collectively contribute to a significant impact on public health as a whole. This also suggests that the reduction of health care costs is substantial if the diseases can be better managed by having a higher physical activity level. A study found that among people who had CVD, the average health care costs among those who met physical activity guidelines were more than SGD 3500 lower than those that did not meet guidelines [52]. Given that approximately one in five adults and one in two older adults live with more than one chronic condition, a large-scale physical activity intervention such as the NSC could be a cost-saving method to reduce the burden of chronic diseases [53].

    One of the parameters that our study results were sensitive to was changes in program compliance (Figure 3C). The scalability and sustainability of a health care intervention are dependent on its acceptability [54]. A study of 132 reviews found that common measures of the acceptability of a health care intervention were attrition (studies: n=44, 33%) and compliance (studies: n=17, 13%) [54]. Better compliance with the intervention could enable participants to reap the benefits of the intervention. Nevertheless, the outreach of the NSC over the first five seasons is promising, reaching over 1.7 million unique participants (52%) in Singapore out of approximately 3.3 million residents aged 17 years and older [27,28]. Although NSC outreach is high and the program is currently cost-saving, our findings also suggest that the program could be even more cost-saving just by improving program compliance.

    The NSC is a nationwide physical activity intervention. Conducting such an intervention has huge costs upfront due to the logistics and the cost of the incentives. However, these costs may eventually be offset due to the reduction in health care utilization due to a lower incidence of chronic diseases from increased physical activity. Since our time horizon is 10 years, we accounted for a plausible range of the differential costs and inflation in our cost-effectiveness analysis. At the same time, we estimate that the upfront financial costs associated with physical activity intervention are only partially mitigated by health care savings and acknowledge the risk that countries might face greater financial barriers due to the high implementation cost.

    Even in the short term (five years), we project that there will be a decrease in the incidence of diabetes and hypertension cases and a decrease in mortality, leading to a reduction in health care costs and QALY gained (Figures S6A-C in Multimedia Appendix 1). Our results suggest that it would still be cost-effective to conduct the NSC in the short term (five years) regardless of whether the benefits of physical activity decreased across the year or persisted for the entire duration of the intervention (Figure S10 in Multimedia Appendix 1). However, the NSC was more cost-saving if conducted for a longer period. If the NSC was conducted throughout the participants’ lifetime, it could be even more cost-saving.

    Comparison With Prior Work

    Our study results were similar to or more cost-effective than those of other cost-effectiveness studies on physical activity interventions (cost per QALY gained of these studies ranged from cost-saving to SGD 133,000) [15,55-66]. An instructor-led walking program, which also provided advice for inactive adults, had an ICER of SGD 133,000 per QALY gained [66]. When compared against other scaled-up physical activity interventions targeting individual behavior, the NSC was more cost-effective. Carrot Rewards, which used a commercial physical activity app, had a closed cohort sample of 38,452 participants (cost per QALY gained was SGD 10,900 over a five year time horizon) [15]. The building of urban greenways, another population-level physical activity intervention, was cost-effective (costs per QALY were SGD 6820 and SGD 28,100) [67]. A community-based physical activity intervention with 266 adults, “10,000 Steps Ghent,” was cost-saving, while another community-based physical activity intervention in the United Kingdom was cost-effective (cost per QALY was SGD 610) [65,68]. Furthermore, the cost-effectiveness of the NSC was similar to many of the RCTs on physical activity interventions included in systematic reviews [56,60,63,69]. The difference in cost-effectiveness of the NSC with other physical activity interventions can be attributed to the fact that the NSC includes all community-dwelling residents and is not focused on high-risk groups. As the incidence of diseases increases with age, the gains in disease reduction are greater among older adults [70,71]. More physical activity interventions targeted toward high-risk populations might be even more cost-effective. However, policy makers may find it difficult to deny interventions to certain groups of the population. Furthermore, it might also be more beneficial to encourage good physical activity behavior from a young age, influencing health in the long run.

    Limitations

    Our analysis made several simplifying assumptions because of model and data limitations. First, as we conducted a closed cohort simulation, we did not consider additional participants who may have joined and benefited from future versions of the NSC. Second, we only modeled two diseases—diabetes and hypertension. There are other benefits from increased physical activity, such as reducing the risks of certain noncommunicable diseases, including lipid disorders (eg, high blood cholesterol) [72], dementia, and certain cancers [73]. Increased physical activity can reduce falls among older adults [74] and also reduce the incidence of the common cold [75]. Increased physical activity also has benefits for mental health, such as protecting against depression [76]. The reduction in the costs of treatment for these diseases and the long-term care costs are not accounted for in our model and would underestimate the NSC’s cost savings. Third, we assumed only one complication per disease and did not include a physical activity level in the complications states due to model complexity constraints and data availability. Fourth, we assumed that an adult would not contract both diabetes and hypertension. As patients with diabetes are likely to have hypertension, we assumed that as long as the adult had diabetes (regardless of whether they had hypertension), the adult would be classified under the diabetes state [77]. CVD is also a complication of both diabetes and hypertension. This would further underestimate the impact of the NSC. Fifth, increased physical activity is associated with increased worker productivity [78]. It may also be worthwhile for companies to introduce programs that promote physical activity in the workplace [78]. All these factors, which were not considered in this analysis, could make the NSC even more cost-saving.

    The study has some methodological limitations. First, as the NSC was a nationwide program and not an RCT, our results do not establish a causal relationship between steps and morbidity or between steps and mortality. Second, selection bias may occur, as participation was voluntary. The NSC participants may be more health-conscious than the general population, leading to an overestimation of the effects of the NSC. Third, we assumed all participants with complications might use inpatient care; there might be an overestimation of the effects of the NSC. Fourth, within the NSC participants, due to the lack of data on noncompliant participants, we were unable to evaluate the difference between those who actively participated versus those who did not. Fifth, participants who were just diagnosed with diabetes, hypertension, or their complications may be more keen to participate in the NSC, whereas participants with advanced stages of complications may have lower levels of physical activity. We were unable to account for these behaviors in our analyses. Sixth, the expected cost of the NSC (SGD 309 million, SGD 36 million each year for 10 years at a 3% discount rate) may also be a limitation. With the anticipated increase in the number of participants, the variable costs associated with the NSC program are likely to rise, particularly due to the provision of participant incentives. Consequently, this may reduce the overall cost-effectiveness of the program. Budget constraints will influence the program’s impact, as larger rewards are associated with larger effects [79]. Furthermore, budget constraints will also determine the program’s level of outreach and engagement. However, the annual implementation of the NSC and our results that the NSC was cost-saving may indicate the sustainability of such a program, at least in high-income countries. This study also informs the long-term monitoring and evaluation (M&E) of physical activity programs in Singapore and should be applicable to other M&E plans for similar programs in other settings. However, we do not advocate the adaption of similar population-based programs without tailored M&E.

    Conclusions

    In conclusion, this modeling study provides evidence of the cost-effectiveness of a nationwide physical activity intervention targeting individual behavior using an app. We projected that increased physical activity from a yearly nationwide physical activity intervention delayed the incidence of diabetes and hypertension and reduced mortality. With a conservative estimate of SGD 448 million in direct health care cost savings, our results suggest that this mHealth physical activity intervention is cost-saving and improves the quality of life. The estimated cost savings are more significant when indirect costs are considered. Hence, our results provide important information for decision-making in countries that may consider introducing similar physical activity programs.

    Acknowledgments

    We thank Ms Yao Jiali for her assistance in the data analysis. We also thank Health Promotion Board for the access to the National Steps Challenge data. This study was supported by the Singapore Ministry of Health’s National Medical Research Council under its Population Health Research Grant (PHRGOC22Jul-0020). GA was supported through the NUS President’s Graduate Fellowship. The funder had no role in the study design, the analysis or interpretation of the data, the writing of the report, or the decision to submit the paper for publication. Grammarly was used to assist in spell-checking and proofreading the manuscript.

    Data Availability

    The datasets generated during and/or analyzed during this study are not publicly available due to concerns regarding sensitivity and confidentiality but are available from the Health Promotion Board Singapore on reasonable request.

    Conflicts of Interest

    None declared.

    Multimedia Appendix 1

    Supplementary information on methodology, model parameters, and model results.

    DOC File, 13104 KB
    Multimedia Appendix 2

    Presentation of the study.

    PPTX File, 6183 KB
    1. Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. Apr 2012;2(2):1143-1211. [CrossRef] [Medline]
    2. Hypertension. World Health Organization. 2021. URL: https://www.who.int/news-room/fact-sheets/detail/hypertension [Accessed 2021-04-30]
    3. Diabetes. World Health Organization. 2022. URL: https://www.who.int/health-topics/diabetes#tab=tab_1 [Accessed 2022-03-16]
    4. Ding D, Lawson KD, Kolbe-Alexander TL, et al. The economic burden of physical inactivity: a global analysis of major non-communicable diseases. Lancet. Sep 24, 2016;388(10051):1311-1324. [CrossRef] [Medline]
    5. National Population Health Survey 2019. Health Promotion Board. 2020. URL: https:/​/www.​hpb.gov.sg/​docs/​default-source/​default-document-library/​national-population-health-survey-2019.​pdf [Accessed 2021-09-20]
    6. Gc VS, Suhrcke M, Atkin AJ, van Sluijs E, Turner D. Cost-effectiveness of physical activity interventions in adolescents: model development and illustration using two exemplar interventions. BMJ Open. Aug 18, 2019;9(8):e027566. [CrossRef] [Medline]
    7. Huai P, Xun H, Reilly KH, Wang Y, Ma W, Xi B. Physical activity and risk of hypertension: a meta-analysis of prospective cohort studies. Hypertension. Dec 2013;62(6):1021-1026. [CrossRef] [Medline]
    8. Lear SA, Hu W, Rangarajan S, et al. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study. Lancet. Dec 16, 2017;390(10113):2643-2654. [CrossRef] [Medline]
    9. Wahid A, Manek N, Nichols M, et al. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis. J Am Heart Assoc. Sep 14, 2016;5(9):e002495. [CrossRef] [Medline]
    10. Sculpher MJ, Claxton K, Drummond M, McCabe C. Whither trial-based economic evaluation for health care decision making? Health Econ. Jul 2006;15(7):677-687. [CrossRef] [Medline]
    11. Katkade VB, Sanders KN, Zou KH. Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making. J Multidiscip Healthc. 2018;11:295-304. [CrossRef] [Medline]
    12. Laranjo L, Ding D, Heleno B, et al. Do smartphone applications and activity trackers increase physical activity in adults? Systematic review, meta-analysis and metaregression. Br J Sports Med. Apr 2021;55(8):422-432. [CrossRef] [Medline]
    13. Romeo A, Edney S, Plotnikoff R, et al. Can smartphone apps increase physical activity? Systematic review and meta-analysis. J Med Internet Res. Mar 19, 2019;21(3):e12053. [CrossRef] [Medline]
    14. Roess A. The promise, growth, and reality of mobile health - another data-free zone. N Engl J Med. Nov 23, 2017;377(21):2010-2011. [CrossRef] [Medline]
    15. Rondina R, Hong M, Sarma S, Mitchell M. Is it worth it? Cost-effectiveness analysis of a commercial physical activity app. BMC Public Health. Oct 27, 2021;21(1):1950. [CrossRef] [Medline]
    16. Kamada M, Hayashi H, Shiba K, et al. Large-scale fandom-based gamification intervention to increase physical activity: a quasi-experimental study. Med Sci Sports Exerc. Jan 1, 2022;54(1):181-188. [CrossRef] [Medline]
    17. Ellingson LD, Lansing JE, DeShaw KJ, et al. Evaluating motivational interviewing and habit formation to enhance the effect of activity trackers on healthy adults’ activity levels: randomized intervention. JMIR Mhealth Uhealth. Feb 14, 2019;7(2):e10988. [CrossRef] [Medline]
    18. Cost-effectiveness analysis for health interventions. World Health Organization. 2022. URL: https://www.who.int/heli/economics/costeffanalysis/en/ [Accessed 2022-02-04]
    19. Iribarren SJ, Cato K, Falzon L, Stone PW. What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. PLoS One. 2017;12(2):e0170581. [CrossRef] [Medline]
    20. Yao J, Tan CS, Chen C, Tan J, Lim N, Müller-Riemenschneider F. Bright spots, physical activity investments that work: National Steps Challenge, Singapore: a nationwide mHealth physical activity programme. Br J Sports Med. Sep 2020;54(17):1047-1048. [CrossRef] [Medline]
    21. Yao J, Lim N, Tan J, et al. Evaluation of a population-wide mobile health physical activity program in 696 907 adults in Singapore. J Am Heart Assoc. Jun 21, 2022;11(12):e022508. [CrossRef] [Medline]
    22. Chew L, Tavitian-Exley I, Lim N, Ong A. Can a multi-level intervention approach, combining behavioural disciplines, novel technology and incentives increase physical activity at population-level? BMC Public Health. Jan 11, 2021;21(1):120. [CrossRef] [Medline]
    23. Ang G, Edney SM, Tan CS, et al. Physical activity trends among adults in a national mobile health program: a population-based cohort study of 411,528 adults. Am J Epidemiol. Feb 24, 2023;192(3):397-407. [CrossRef] [Medline]
    24. Png ME, Yoong J, Phan TP, Wee HL. Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050. BMC Public Health. Feb 16, 2016;16:153. [CrossRef] [Medline]
    25. Wierzejska E, Giernaś B, Lipiak A, Karasiewicz M, Cofta M, Staszewski R. A global perspective on the costs of hypertension: a systematic review. Arch Med Sci. 2020;16(5):1078-1091. [CrossRef] [Medline]
    26. Medical technologies evaluation methods and process guide. Agency for Care Effectiveness. 2022. URL: https:/​/www.​ace-hta.gov.sg/​docs/​default-source/​process-methods/​ace-med-tech-evaluation-methods-and-process-guide-(mar-2022).​pdf [Accessed 2022-05-27]
    27. Population and population structure. Department of Statistics Singapore. 2020. URL: https:/​/www.​singstat.gov.sg/​find-data/​search-by-theme/​population/​population-and-population-structure/​latest-data [Accessed 2020-07-21]
    28. Steep fall in physical activity during circuit breaker period: HPB. The Straits Times. 2022. URL: https:/​/www.​straitstimes.com/​singapore/​steep-fall-in-physical-activity-during-circuit-breaker-period-health-promotion-board [Accessed 2022-05-18]
    29. National Health Survey 2010. Ministry of Health Singapore. 2011. URL: https://www.moh.gov.sg/resources-statistics/reports/national-health-survey-2010 [Accessed 2019-11-19]
    30. Tan KHX, Tan LWL, Sim X, et al. Cohort profile: the Singapore Multi-Ethnic Cohort (MEC) study. Int J Epidemiol. Jun 1, 2018;47(3):699-699j. [CrossRef] [Medline]
    31. Complete life tables for Singapore resident population, 2018-2019. Department of Statistics Singapore. 2020. URL: https://www.singstat.gov.sg/publications/population/complete-life-table [Accessed 2020-08-10]
    32. Yang JJ, Yu D, Wen W, et al. Association of diabetes with all-cause and cause-specific mortality in Asia: a pooled analysis of more than 1 million participants. JAMA Netw Open. Apr 5, 2019;2(4):e192696. [CrossRef] [Medline]
    33. Lee J, Ma S, Heng D, Chew S, Hughes K, Tai E. Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore cardiovascular cohort study. J Hum Hypertens. Jul 2008;22(7):468-474. [CrossRef] [Medline]
    34. Official exchange rate (LCU per US$, period average). The World Bank Group. 2021. URL: https://data.worldbank.org/indicator/PA.NUS.FCRF [Accessed 2021-09-24]
    35. Fee benchmarks and bill amount information. Ministry of Health Singapore. 2019. URL: https://www.moh.gov.sg/cost-financing/fee-benchmarks-and-bill-amount-information/ [Accessed 2019-11-19]
    36. Shuyu Ng C, Toh MPHS, Ko Y, Yu-Chia Lee J. Direct medical cost of type 2 diabetes in Singapore. PLoS One. 2015;10(3):e0122795. [CrossRef] [Medline]
    37. Tan SY, Lew KJ, Xie Y, et al. Healthcare cost of patients with multiple chronic diseases in Singapore public primary care setting. Ann Acad Med Singap. Nov 30, 2021;50(11):809-817. [CrossRef]
    38. National Population Health Survey 2020 (household interview and health examination). Ministry of Health Singapore. 2020. URL: https://www.moh.gov.sg/docs/librariesprovider5/default-document-library/nphs-2020-survey-report.pdf [Accessed 2022-03-16]
    39. Annual report 2018/2019. Health Promotion Board. 2019. URL: https:/​/www.​hpb.gov.sg/​docs/​default-source/​annual-reports/​hpb-annual-report-2018_2019.​pdf?sfvrsn=df71c372_0 [Accessed 2022-09-05]
    40. Health programmes. Health Hub. 2022. URL: https://www.healthhub.sg/Programmes [Accessed 2022-04-19]
    41. Abdin E, Subramaniam M, Vaingankar JA, Luo N, Chong SA. Population norms for the EQ-5D index scores using Singapore preference weights. Qual Life Res. Jun 2015;24(6):1545-1553. [CrossRef] [Medline]
    42. Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: the associations of complications with EQ-5D scores. Health Qual Life Outcomes. Feb 4, 2010;8:18. [CrossRef] [Medline]
    43. Bauer D, Lakdawalla D, Reif J. Mortality risk, insurance, and the value of life. Natl Bureau Econ Res Working Paper Ser. 2019:25055. [CrossRef]
    44. Sato M, Du J, Inoue Y, Funk DC, Weaver F. Older adults’ physical activity and healthcare costs, 2003–2014. Am J Prev Med. May 2020;58(5):e141-e148. [CrossRef]
    45. Dallmeyer S, Wicker P, Breuer C. The relationship between physical activity and out-of-pocket health care costs of the elderly in Europe. Eur J Public Health. Aug 1, 2020;30(4):628-632. [CrossRef] [Medline]
    46. National Population Health Survey 2022. Ministry of Health Singapore. 2023. URL: https:/​/www.​moh.gov.sg/​docs/​librariesprovider5/​resources-statistics/​reports/​nphs-2022-survey-report-(final).​pdf [Accessed 2024-03-02]
    47. National Accounts. Department of Statistics Singapore. 2021. URL: https://www.singstat.gov.sg/find-data/search-by-theme/economy/national-accounts/latest-data [Accessed 2021-04-27]
    48. Bertram MY, Lauer JA, De Joncheere K, et al. Cost-effectiveness thresholds: pros and cons. Bull World Health Organ. Dec 1, 2016;94(12):925-930. [CrossRef] [Medline]
    49. Woods B, Revill P, Sculpher M, Claxton K. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health. Dec 2016;19(8):929-935. [CrossRef]
    50. Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med. Feb 14, 2008;358(7):661-663. [CrossRef] [Medline]
    51. Current health expenditure (% of GDP). The World Bank Group. 2021. URL: https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS [Accessed 2021-04-30]
    52. Valero-Elizondo J, Salami JA, Osondu CU, et al. Economic impact of moderate-vigorous physical activity among those with and without established cardiovascular disease: 2012 Medical Expenditure Panel Survey. J Am Heart Assoc. Sep 7, 2016;5(9):e003614. [CrossRef] [Medline]
    53. Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. Sep 2011;10(4):430-439. [CrossRef] [Medline]
    54. Klaic M, Kapp S, Hudson P, et al. Implementability of healthcare interventions: an overview of reviews and development of a conceptual framework. Implement Sci. Jan 27, 2022;17(1):10. [CrossRef] [Medline]
    55. Abu-Omar K, Rütten A, Burlacu I, Schätzlein V, Messing S, Suhrcke M. The cost-effectiveness of physical activity interventions: a systematic review of reviews. Prev Med Rep. Dec 2017;8:72-78. [CrossRef] [Medline]
    56. Wolfenstetter SB, Wenig CM. Economic evaluation and transferability of physical activity programmes in primary prevention: a systematic review. Int J Environ Res Public Health. Apr 2010;7(4):1622-1648. [CrossRef] [Medline]
    57. GC V, Wilson ECF, Suhrcke M, Hardeman W, Sutton S, VBI Programme Team. Are brief interventions to increase physical activity cost-effective? A systematic review. Br J Sports Med. Apr 2016;50(7):408-417. [CrossRef] [Medline]
    58. Campbell F, Holmes M, Everson-Hock E, et al. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report. Health Technol Assess. Jul 2015;19(60):1-110. [CrossRef] [Medline]
    59. Pavey TG, Anokye N, Taylor AH, et al. The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation. Health Technol Assess. Dec 2011;15(44):i-xii. [CrossRef] [Medline]
    60. Gordon L, Graves N, Hawkes A, Eakin E. A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol. Chronic Illn. Jun 2007;3(2):101-129. [CrossRef] [Medline]
    61. Windle G, Hughes D, Linck P, Russell I, Woods B. Is exercise effective in promoting mental well-being in older age? A systematic review. Aging Ment Health. Aug 2010;14(6):652-669. [CrossRef]
    62. Müller-Riemenschneider F, Reinhold T, Willich SN. Cost-effectiveness of interventions promoting physical activity. Br J Sports Med. Jan 2009;43(1):70-76. [CrossRef] [Medline]
    63. Garrett S, Elley CR, Rose SB, O’Dea D, Lawton BA, Dowell AC. Are physical activity interventions in primary care and the community cost-effective? A systematic review of the evidence. Br J Gen Pract. Mar 2011;61(584):e125-e133. [CrossRef] [Medline]
    64. Lehnert T, Sonntag D, Konnopka A, Riedel-Heller S, König HH. The long-term cost-effectiveness of obesity prevention interventions: systematic literature review. Obes Rev. Jun 2012;13(6):537-553. [CrossRef] [Medline]
    65. De Smedt D, De Cocker K, Annemans L, De Bourdeaudhuij I, Cardon G. A cost-effectiveness study of the community-based intervention ‘10 000 Steps Ghent.’. Public Health Nutr. Mar 2012;15(3):442-451. [CrossRef] [Medline]
    66. Isaacs AJ, Critchley JA, Tai SS, et al. Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only. Health Technol Assess. Mar 2007;11(10):1-165, iii-iv. [CrossRef] [Medline]
    67. Dallat MAT, Soerjomataram I, Hunter RF, Tully MA, Cairns KJ, Kee F. Urban greenways have the potential to increase physical activity levels cost-effectively. Eur J Public Health. Apr 2014;24(2):190-195. [CrossRef] [Medline]
    68. Frew EJ, Bhatti M, Win K, et al. Cost-effectiveness of a community-based physical activity programme for adults (Be Active) in the UK: an economic analysis within a natural experiment. Br J Sports Med. Feb 2014;48(3):207-212. [CrossRef] [Medline]
    69. Williams NH, Hendry M, France B, Lewis R, Wilkinson C. Effectiveness of exercise-referral schemes to promote physical activity in adults: systematic review. Br J Gen Pract. Dec 1, 2007;57(545):979-986. [CrossRef]
    70. Kehler DS. Age-related disease burden as a measure of population ageing. Lancet Public Health. Mar 2019;4(3):e123-e124. [CrossRef] [Medline]
    71. Chang AY, Skirbekk VF, Tyrovolas S, Kassebaum NJ, Dieleman JL. Measuring population ageing: an analysis of the Global Burden of Disease Study 2017. Lancet Public Health. Mar 2019;4(3):e159-e167. [CrossRef] [Medline]
    72. Chronic diseases: understanding the medical conditions and their causes. Health Hub. 2020. URL: https://www.healthhub.sg/a-z/diseases-and-conditions/96/topics_chronic_diseases [Accessed 2020-12-07]
    73. Katzmarzyk PT, Friedenreich C, Shiroma EJ, Lee IM. Physical inactivity and non-communicable disease burden in low-income, middle-income and high-income countries. Br J Sports Med. Jan 2022;56(2):101-106. [CrossRef] [Medline]
    74. Sherrington C, Fairhall N, Kwok W, et al. Evidence on physical activity and falls prevention for people aged 65+ years: systematic review to inform the WHO guidelines on physical activity and sedentary behaviour. Int J Behav Nutr Phys Act. Nov 26, 2020;17(1):144. [CrossRef] [Medline]
    75. Nieman DC, Henson DA, Austin MD, Sha W. Upper respiratory tract infection is reduced in physically fit and active adults. Br J Sports Med. Sep 2011;45(12):987-992. [CrossRef] [Medline]
    76. Kadariya S, Gautam R, Aro AR. Physical activity, mental health, and wellbeing among older adults in South and Southeast Asia: a scoping review. Biomed Res Int. 2019;2019:6752182. [CrossRef] [Medline]
    77. de Boer IH, Bangalore S, Benetos A, et al. Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes Care. Sep 2017;40(9):1273-1284. [CrossRef] [Medline]
    78. Grimani A, Aboagye E, Kwak L. The effectiveness of workplace nutrition and physical activity interventions in improving productivity, work performance and workability: a systematic review. BMC Public Health. Dec 12, 2019;19(1):1676. [CrossRef] [Medline]
    79. Mok A, Khaw KT, Luben R, Wareham N, Brage S. Physical activity trajectories and mortality: population based cohort study. Br Med J. Jun 26, 2019;365:l2323. [CrossRef] [Medline]

    ‎
    CVD: cardiovascular disease
    GDP: gross domestic product
    ICER: increment cost-effectiveness ratio
    M&E: monitoring and evaluation
    mHealth: mobile health
    NSC: National Steps Challenge
    QALY: quality-adjusted life-year
    RCT: randomized controlled trials
    SGD: Singapore dollar

    Edited by Amaryllis Mavragani; submitted 01.02.23; peer-reviewed by Debin Wang, Ronald Sigal; final revised version received 16.03.24; accepted 16.05.24; published 04.10.24.

    Copyright

    © Gregory Ang, Chuen Seng Tan, Yot Teerawattananon, Falk Müller-Riemenschneider, Cynthia Chen. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 4.10.2024.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.